Skip to content

Low-level RED Light-Low Concentration Atropine for Myopia Progression Study (RED-LAMP)

Low-level RED Light-Low Concentration Atropine for Myopia Progression Study (RED-LAMP)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067255
Enrollment
Unknown
Registered
2023-01-01
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Group 1:0.05% atropine: both eyes once daily
Group 2:0.9% normal saline once daily and low-level red light therapy for 3 minutes twice per school day at home with interval of at least 4 hours
Group 3:0.05% atropine both eyes once daily and low-level red light therapy twice per school day at home with an interval of at least 4 hours
each treatment lasts for 3 minutes
Group 4:0.9% normal saline: both eyes once daily

Sponsors

Department of Ophthalmology and Visual Sciences, Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Aged 4-12 years; 2. Myopia (1 to 10 D) in one eye; 3. Astigmatism less than 2.5 days; 4. Anisometropia less than 2.0D; 5. Informed consent of the patient's parents.

Exclusion criteria

Exclusion criteria: 1. Eye diseases other than ametropia. 2. Past treatment with atropine. 3. Allergy or intolerance to atropine. 4. Unable to participate in regular follow-up evaluations.

Design outcomes

Primary

MeasureTime frame
Myopic progression: change in spherical equivalent refraction;Eyeball growth: change in axial length;

Secondary

MeasureTime frame
Safety;

Countries

China

Contacts

Public ContactYam Cheuk Sing Jason

Department of Ophthalmology and Visual Sciences, Chinese University of Hong Kong

yamcheuksing@cuhk.edu.hk+852 39435892

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026